Cleared Special

K211344 - MICRUSFRAME, DELTAFILL, DELTAXSFT, GALAXY G3, GALAXY G3 XSFT, and GALAXY G3 Mini Microcoil Delivery Systems (FDA 510(k) Clearance)

May 2021
Decision
25d
Days
Class 2
Risk

K211344 is an FDA 510(k) clearance for the MICRUSFRAME, DELTAFILL, DELTAXSFT, GALAXY G3, GALAXY G3 XSFT, and GALAXY G3 Mini Microcoil Delivery Systems. This device is classified as a Device, Neurovascular Embolization (Class II - Special Controls, product code HCG).

Submitted by Medos International SARL (Le Locle, CH). The FDA issued a Cleared decision on May 28, 2021, 25 days after receiving the submission on May 3, 2021.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5950.

Submission Details

510(k) Number K211344 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 2021
Decision Date May 28, 2021
Days to Decision 25 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code HCG — Device, Neurovascular Embolization
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5950

Similar Devices — HCG Device, Neurovascular Embolization

All 7
Target Detachable Coil
K252694 · Stryker Neurovascular · Dec 2025
InZone IST Detachment System
K251832 · Stryker Neurovascular · Oct 2025
Penumbra LP Coil System
K230284 · Penumbra, Inc. · Oct 2023
Target Tetra Detachable Coils
K222533 · Stryker Neurovascular · Dec 2022
CEREPAK Uniform, Uniform XL, Uniform 3D, Heliform Soft, Heliform XtraSoft, Heliform XL, Heliform XtraSoft XL, Freeform, Freeform Mini, and Freeform XtraSoft Detachable Coil Systems
K220040 · Medos International SARL · Jul 2022
InZone Detachment System
K212455 · Stryker Neurovascular · Nov 2021